KKAMG
GILD icon

Kernodle & Katon Asset Management Group’s Gilead Sciences GILD Stock Holding History

Kernodle & Katon Asset Management Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$48K Buy
712
+2
+0.3% +$141 0.03% 166
2016
Q4 		$51K Sell
710
-200
-22% -$14.9K 0.03% 163
2016
Q3 		$72K Hold
910
– – 0.04% 155
2016
Q2 		$76K Hold
910
– – 0.07% 102
2016
Q1 		$84K Hold
910
– – 0.08% 92
2015
Q4 		$92K Buy
+910
New +$94.7K 0.09% 80

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Kernodle & Katon Asset Management Group's GILD Position: Q1 2017 in Review

Kernodle & Katon Asset Management Group increased its Gilead Sciences (GILD) stake by 0.28% in Q1 2017, buying an estimated $141 and bringing the position to 712 shares worth $48K. The position accounts for 0.03% of the portfolio, ranked #166.

Kernodle & Katon Asset Management Group first reported a position in GILD in Q4 2015 and has held it in 6 quarters since. The position peaked at $92K in Q4 2015. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Kernodle & Katon Asset Management Group held 712 shares of Gilead Sciences worth $48K as of Q1 2017.
  • Kernodle & Katon Asset Management Group bought 2 Gilead Sciences shares in Q1 2017, an estimated $141.
  • Gilead Sciences made up 0.03% of Kernodle & Katon Asset Management Group's portfolio in Q1 2017, its #166 holding.
  • Kernodle & Katon Asset Management Group first reported a position in Gilead Sciences in Q4 2015 and has held it in 6 quarters since.
  • Kernodle & Katon Asset Management Group's Gilead Sciences position peaked at $92K in Q4 2015.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Kernodle & Katon Asset Management Group's 13F filing for Q1 2017, filed 12 May 2017.